Trials / Completed
CompletedNCT02556749
Effects of Cranberry Juice on Cardiovascular Risk Factors
Effects of Cranberry Juice on Cardiovascular Risk Factors in a Placebo-controlled Crossover Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Penn State University · Academic / Other
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effects of cranberry juice on central and peripheral blood pressure, indices of arterial stiffness, lipid and lipoprotein concentrations and size characteristics, and HDL function. The investigators hypothesize that the bioactive compounds in cranberry juice may elicit beneficial effects on blood pressure and arterial health, as well as LDL-C and HDL function.
Detailed description
The investigators propose to conduct a 2-period randomized, crossover, placebo-controlled study to evaluate the effect of cranberry juice on central and peripheral blood pressure, indices of arterial stiffness, lipid and lipoprotein concentrations and size characteristics, and HDL function. Eligibility requires non-smoking men and women to be 30 to 65 years of age with BMI greater than or equal to 18 and less than or equal to 39, total cholesterol below 273 mg/dL for men and below 284 mg/dL for women, triglycerides below 350 mg/dL, and have systolic blood pressure of 120 to 159 mmHg and/or diastolic blood pressure of 80 to 99 mmHg. Subjects will undergo randomized treatments including 500 mL/d cranberry juice beverage and 500 mL/d of a color and taste matched placebo beverage. The two 8 to 12 week treatment periods will be separated by an 8 week washout.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Cranberry Juice Beverage | 16 ounces of 54% cranberry juice cocktail |
| DIETARY_SUPPLEMENT | Placebo Beverage | Color, calorie, and taste matched beverage without cranberry bioactives |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2019-05-01
- Completion
- 2019-05-01
- First posted
- 2015-09-22
- Last updated
- 2023-08-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02556749. Inclusion in this directory is not an endorsement.